WuXi Apptec Articles

WuXi AppTec opens first cGMP biologics facility in China

21 October 2012

AstraZeneca partners with WuXi AppTec to speed novel biologic to Chinese market

11 September 2012

WuXi PharmaTech acquires China-based clinical services companies; ShangPharma buys Charles River research facility

25 October 2011

WuXi PharmaTech gains GLP Certificate from OECD for Suzhou toxicology facility

22 September 2010

Charles River calls off WuXi Pharmatech buy on shareholder opposition; Pfizer sells Idun to Conatus

2 August 2010

Charles River Labs to acquire China’s WuXi PharmaTech for $1.6 billion, creating global CRO; PPD opens vaccine research center in China

27 April 2010

Showing 1-6 of 6 articles

Go to beginningPrevious
  • 1
NextGo to end